Investigating Typhoid Fever Pathogenesis (TYGER)

You are invited to take part in a study to investigate typhoid fever and how the typhoid bacteria causes disease.  The study is being run by the Oxford Vaccine Group which is part of the University of Oxford.

If you are 18 to 60 yrs old, in good health and have not previously received a typhoid vaccine then you may be eligible to take part in the study. We will provide reimbursement for your time, inconvenience and travel. The total study participation time is 12 months.

Background

ImmunoglobuliN in the Treatment of Encephalitis

The IgNiTE Study

A study testing a new treatment for children with encephalitis.

The Department of Paediatrics at the University of Oxford, in collaboration with NHS Trusts across the United Kingdom, is currently running a study for hospitalised children with encephalitis. The study will assess whether a treatment called intravenous immunoglobulin (IVIg, sometimes referred to as antibody treatment) has any benefit for these children when given early during the hospital admission.

Subscribe to Trials - Oxford Vaccine Group RSS